Treating Leukemia in the Time of COVID-19

The coronavirus disease 2019 (COVID-19) pandemic poses several challenges to the management of patients with leukemia. The biology of each leukemia and its corresponding treatment with conventional intensive chemotherapy, with or without targeted therapies (venetoclax, FLT3 inhibitors, IDH1/2 inhibi...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Acta Haematol
Päätekijät: Paul, Shilpa, Rausch, Caitlin R., Jain, Nitin, Kadia, Tapan, Ravandi, Farhad, DiNardo, Courtney D., Welch, Mary Alma, Dabaja, Bouthaina S., Daver, Naval, Garcia-Manero, Guillermo, Wierda, William, Pemmaraju, Naveen, Montalban Bravo, Guillermo, Thompson, Philip, Verstovsek, Srdan, Konopleva, Marina, Kantarjian, Hagop, Jabbour, Elias
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: S. Karger AG 2020
Aiheet:
Review
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7270066/
https://ncbi.nlm.nih.gov/pubmed/32392559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000508199
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia